Cargando…
Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer
Maintaining thiol homeostasis is an imperative for cancer cell survival in the nutrient-deprived microenvironment of solid tumors. Despite this metabolic vulnerability, a selective approach has yet to be developed to disrupt thiol homeostasis in solid tumors for therapeutic purposes. In this study,...
Autores principales: | DuHadaway, James, Prendergast, George C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884924/ https://www.ncbi.nlm.nih.gov/pubmed/26840263 http://dx.doi.org/10.18632/oncotarget.7058 |
Ejemplares similares
-
The oncolytic peptide LTX-315 kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization
por: Zhou, Heng, et al.
Publicado: (2015) -
Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer
por: Vendetti, Frank P., et al.
Publicado: (2014) -
New antimetabolites in cancer chemotherapy and their clinical impact.
por: Kaye, S. B.
Publicado: (1998) -
PS consoles module TTL/TTL distributor No. 80214
por: Debordes, R
Publicado: (1979) -
TTL cookbook
por: Lancaster, Don
Publicado: (1974)